Proceedings: Cyclophosphamide and the kidney.
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000652:urine; D001835:Body Weight; D002118:Calcium / Q000652:urine; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced; D004231:Diuresis / Q000187:drug effects; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced; D007668:Kidney / Q000187:drug effects*; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D009369:Neoplasms / Q000188:drug therapy*; D009994:Osmolar Concentration; D010758:Phosphorus / Q000652:urine; D011188:Potassium / Q000652:urine; D011507:Proteinuria; D014527:Uric Acid / Q000652:urine; D014667:Vasopressins / Q000097:blood
D000596:Amino Acids; D014667:Vasopressins; D014527:Uric Acid; D010758:Phosphorus; D003520:Cyclophosphamide; D011188:Potassium; D002118:Calcium